2009 May
An astonishing example of glaring anti-supplement bias in a clinical study
Read more...A team of U.S. and German researchers tested the effect of large doses of vitamins C and E (or placebo) in nearly 40 young men who took part in a rigorous four-week exercise regimen.
Could it now be easier than ever to get a new drug approved by the FDA?
Read more...A recent Reuters Health report notes the FDA approval of Fanapt, a powerful atypical antipsychotic drug that treats schizophrenia.
Testosterone gel gets an urgent new safety warning
Read more...The FDA informed testosterone gel makers that they’re now required to include a black box warning with the packaging of their medications
Statin drugs may impact PSA levels – even in men with prostate cancer
Read more...A new study reveals yet another reason to steadfastly avoid Lipitor, Zocor, Crestor and all the rest of the dangerous brand names in this drug class.
Sugar Free aspirin? How’s that again?
Read more...It’s a come-on aimed at diabetic customers whom Bayer execs apparently presume are so hypnotized by the words “Sugar Free” that they’ll purchase any product with those words on the packaging.